Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01242865 · ClinicalTrials.gov registry record · NA

Self Help Intervention to Decrease Stress

A NA study of Stress, Psychological, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
33
Enrollment target
1
Study location

NCT01242865: Completed NA study of Stress, Psychological, sponsored by Mayo Clinic.

NCT01242865 is a NA study of Stress, Psychological that has completed, run by Mayo Clinic. The registered enrollment target is 33 participants, below the 171-participant average among 43 other Stress, Psychological trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT01242865, a NA study of Stress, Psychological, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
33 participants
Enrollment target
1
Study location

Study Summary

The present study is designed to test the feasibility and efficacy of a stand alone self help program for decreasing stress and anxiety and enhancing quality of life. The intervention will be offered in the form of a self help book and three handouts with no in-person instructor time.

Conditions Studied

Interventions

  • BEHAVIORAL Attention and Interpretation Therapy

Study Locations (1)

Minnesota

  • Mayo Clinic - Rochester

Trial Details

FieldValue
Enrollment Target 33 participants
Start Date 2010-12
Est. Completion 2012-01
Phase NA
Mayo Clinic

2,844 total trials

What the finished NCT01242865 record still lists

NCT01242865 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 33 participants, a relatively small participant target, below the 171-participant average among 43 other Stress, Psychological trials with a reported enrollment target (81% lower).

The record links to 1 condition, with Stress, Psychological appearing as the primary indexed condition, and to 1 intervention - of which Attention and Interpretation Therapy is the first listed.

NCT01242865 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT01242865 about?

NCT01242865 is a clinical study titled "Self Help Intervention to Decrease Stress". The present study is designed to test the feasibility and efficacy of a stand alone self help program for decreasing stress and anxiety and enhancing quality of life. The intervention will be offered in the form of a self help book and three handouts with no in-person instructor time.

What is the current status of trial NCT01242865?

This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2010-12. Estimated completion is 2012-01.

What conditions does trial NCT01242865 study?

This clinical trial studies the following conditions: Stress, Psychological.

What interventions are being tested in trial NCT01242865?

The interventions under investigation include: Attention and Interpretation Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT01242865?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01242865 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stress, Psychological

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01242865's enrollment target sits among peer trials

33 39th of 43 higher than 5 of 43 other Stress, Psychological trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Stress, Psychological trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02861898 · 33 participants · Phase 1

    Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma

  • NCT04871607 · 33 participants · Phase 2

    Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma

  • NCT05071937 · 33 participants · Phase 2

    ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer

  • NCT05168618 · 33 participants · Phase 2

    Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01242865, the US trial registry maintained by the National Library of Medicine. NCT01242865 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.